Gut Permeability-related Inflammation and Cardiovascular Disease Risk in Normal-weight and Metabolically Healthy Obesity

NCT05308394 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2022-04-15

No results posted yet for this study

Summary

The investigators are examining the extent gut permeability explains observed inflammation in normal-weight and metabolically healthy obesity (and potentially cardiovascular disease risk).

Conditions

Interventions

OTHER

No experimental intervention will take place - the study is cross-sectional. Each participant will provide biological samples.

Each participant will provide a blood and fecal sample.

Sponsors & Collaborators

  • Oklahoma State University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-10
Primary Completion
2022-12-30
Completion
2022-12-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05308394 on ClinicalTrials.gov